Anebulo Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ANEB and other ETFs, options, and stocks.About ANEB
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1.
CEORichard Anthony Cunningham
CEORichard Anthony Cunningham
Employees3
Employees3
HeadquartersLakeway, Texas
HeadquartersLakeway, Texas
Founded2020
Founded2020
Employees3
Employees3
ANEB Key Statistics
Market cap93.34M
Market cap93.34M
Price-Earnings ratio-9.69
Price-Earnings ratio-9.69
Dividend yield—
Dividend yield—
Average volume19.41K
Average volume19.41K
High today$2.29
High today$2.29
Low today$2.27
Low today$2.27
Open price$2.27
Open price$2.27
Volume2.14K
Volume2.14K
52 Week high$3.42
52 Week high$3.42
52 Week low$0.8001
52 Week low$0.8001
Stock Snapshot
As of today, Anebulo Pharmaceuticals(ANEB) shares are valued at $2.27. The company's market cap stands at 93.34M, with a P/E ratio of -9.69.
As of 2025-11-17, Anebulo Pharmaceuticals(ANEB) stock has fluctuated between $2.27 and $2.29. The current price stands at $2.27, placing the stock +0.1% above today's low and -0.8% off the high.
The Anebulo Pharmaceuticals(ANEB)'s current trading volume is 2.14K, compared to an average daily volume of 19.41K.
During the past year, Anebulo Pharmaceuticals(ANEB) stock moved between $0.80 at its lowest and $3.42 at its peak.
During the past year, Anebulo Pharmaceuticals(ANEB) stock moved between $0.80 at its lowest and $3.42 at its peak.
People also own
Based on the portfolios of people who own ANEB. This list is generated using Robinhood data, and it’s not a recommendation.